Why the study?
Does the extent of myocardial viability assessed by PET imaging predict improvement in heart failure symptoms after CABG in patients with ischemic cardiomyopathy?
Population
Patients with ischemic cardiomyopathy
Design
Cohort
Authors
Loading...
Viability by PET may predict CABG symptom benefit in ischemic cardiomyopathy; extends observational data but leaves open randomized confirmation.
Does the extent of myocardial viability assessed by PET imaging predict improvement in heart failure symptoms after CABG in patients with ischemic cardiomyopathy?
Preoperative assessment of myocardial viability using PET imaging can help identify patients with ischemic cardiomyopathy who will derive the greatest symptomatic benefit from surgical revascularization.
Carli et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: